MedTrace Logo

Clinical Validation of the Apollo Daily Disposable Soft Contact Lenses

NCT05035017 · Status: COMPLETED · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2024-08-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to confirm the design specifications of a Test lens and validate its clinical performance.

Conditions

  • Myopia

Interventions

DEVICE

Test Lens

Daily disposable with modified lens design for 2 days

DEVICE

Control Lens

Daily disposable lens for 2 days

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-17
Primary Completion
2021-07-31
Completion
2021-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05035017 on ClinicalTrials.gov